DRUG-DRUG INTERACTION PROFILE OF TEZACAFTOR/ IVACAFTOR IN HEALTHY ADULT SUBJECTS

被引：0
|
作者：
Garg, V [1 ]
Shen, J. [1 ]
Li, C. [1 ]
Agarwal, S. [1 ]
Gebre, A. [1 ]
Parkinson, J. [1 ]
Robertson, S. [1 ]
Viswanathan, L. [1 ]
Huang, J. [1 ]
Han, L. [1 ]
Lekstrom-Himes, J. [1 ]
机构：
[1] Vertex Pharmaceut Inc, Boston, MA USA
来源：
PEDIATRIC PULMONOLOGY | 2017年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
254
引用
收藏
页码：S310 / S310
页数：1
相关论文
共 50 条
  • [41] Drug-drug interaction profile of oxcarbazepine in children and adults
    Hossain, M
    Sallas, W
    Gasparini, M
    D'Souza, J
    NEUROLOGY, 1999, 52 (06) : A525 - A525
  • [42] Drug-drug plasma protein binding interactions of ivacaftor
    Schneider, Elena K.
    Huang, Johnny X.
    Carbone, Vincenzo
    Baker, Mark
    Azad, Mohammad A. K.
    Cooper, Matthew A.
    Li, Jian
    Velkov, Tony
    JOURNAL OF MOLECULAR RECOGNITION, 2015, 28 (06) : 339 - 348
  • [43] Drug-drug interaction study of ciprofol and sodium divalproex: Pharmacokinetics, pharmacodynamics, and safety in healthy Chinese subjects
    Yang, Dandan
    Zhang, Wei
    Ruan, Zourong
    Jiang, Bo
    Huang, Siqi
    Wang, Jiaying
    Zhao, Pengfei
    Hu, Mengyue
    Yan, Min
    Lou, Honggang
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (10): : 1972 - 1981
  • [44] A drug-drug interaction study between rosuvastatin and pantoprazole after oral administration in healthy male subjects
    Huguet, Jade
    Gaudette, Fleur
    Belanger, Francois
    Chiasson, Jean-Louis
    Hamet, Pavel
    Turgeon, Jacques
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (09): : 1330 - 1330
  • [45] Drug-Drug Interaction Study of ACT-178882, a New Renin Inhibitor, and Diltiazem in Healthy Subjects
    Dingemanse, Jasper
    Nicolas, Laurent
    CLINICAL DRUG INVESTIGATION, 2013, 33 (03) : 207 - 213
  • [46] Pharmacokinetics and drug-drug interaction between enalapril, enalaprilat and felodipine extended release (ER) in healthy subjects
    Li, Dai
    Xu, Sumei
    Wang, Yulu
    Li, Dan
    Li, Xiaomin
    Pan, Jing
    Xu, Pingsheng
    ONCOTARGET, 2017, 8 (41) : 70752 - 70760
  • [47] DRUG-DRUG INTERACTION POTENTIAL OF GILTERITINIB IN HEALTHY SUBJECTS AND PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
    Levis, M.
    Smith, C.
    Litzow, M.
    Perl, A.
    Altman, J.
    James, A.
    Kadokura, T.
    Sargent, B.
    Yuen, G.
    Lu, Z.
    Liu, C.
    Nagase, I.
    Bahceci, E.
    HAEMATOLOGICA, 2017, 102 : 386 - 386
  • [48] Pharmacokinetic Drug-Drug Interaction Study of Omecamtiv Mecarbil With Omeprazole, a Proton Pump Inhibitor, in Healthy Subjects
    Trivedi, Ashit
    Sohn, Winnie
    Jafarinasabian, Pegah
    Zhang, Hanze
    Terminello, Bianca
    Flach, Stephen
    Abbasi, Siddique
    Dutta, Sandeep
    Lee, Edward
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (01): : 129 - 133
  • [49] Drug-Drug Interaction Study of ACT-178882, a New Renin Inhibitor, and Diltiazem in Healthy Subjects
    Jasper Dingemanse
    Laurent Nicolas
    Clinical Drug Investigation, 2013, 33 : 207 - 213
  • [50] EFFECTS OF EZOGABINE/RETIGABINE ON THE PHARMACOKINETICS OF DIGOXIN IN HEALTHY SUBJECTS: RESULTS FROM A DRUG-DRUG INTERACTION STUDY
    Crean, C.
    Tompson, D.
    Buraglio, M.
    EPILEPSIA, 2013, 54 : 166 - 166
12345